The Baidu Capital and Intuitive Surgical-backed lung disease-focused medical devices developer’s Hong Kong offering valued it at about $1.3bn.

Broncus, a US-based medical equipment developer backed by corporate investors Baidu and Intuitive Surgical, floated on the Hong Kong Stock Exchange on Friday in a HK$1.67bn ($215m) initial public offering.

The offering entailed the company issuing almost 89.4 million shares priced at the upper end of the IPO’s HK$17.20 to $HK$18.70 range, giving it a market capitalisation of roughly HK$10bn ($1.3bn). The shares opened and closed at HK$18.00 and HK$15.00 respectively on the first day of trading.

Founded in…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn